Pembrolizumab in mycosis fungoides with PD-L1 structural variants

PD-L1 structural variants are recurrent in mycosis fungoides with large cell transformation. PD-L1 structural variants in relapsed/refractory mycosis fungoides should prompt consideration of treatment with PD-1 inhibitors.

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Adv
Autori principali: Beygi, Sara, Fernandez-Pol, Sebastian, Duran, George, Wang, Erica B., Stehr, Henning, Zehnder, James L., Ramchurren, Nirasha, Fling, Steven P., Cheever, Martin A., Weng, Wen-Kai, Kim, Youn H., Khodadoust, Michael S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society of Hematology 2021
Soggetti:
Stimulus Report
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7876893/
https://ncbi.nlm.nih.gov/pubmed/33560388
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002371
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi